We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$774M
AUM Growth
+$15.3M
Cap. Flow
-$9.61M
Cap. Flow %
-1.24%
Top 10 Hldgs %
26.39%
Holding
284
New
7
Increased
63
Reduced
151
Closed
12

Top Buys

Rank Stock Value
1
IBKR icon
Interactive Brokers
IBKR
+$920K
2
AAPL icon
Apple
AAPL
+$848K
3
CAT icon
Caterpillar
CAT
+$737K
4
VAW icon
Vanguard Materials ETF
VAW
+$304K
5
IBM icon
IBM
IBM
+$298K

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$978K
2
RS icon
Reliance Steel & Aluminium
RS
+$643K
3
NBIX icon
Neurocrine Biosciences
NBIX
+$483K
4
ACO
AMCOL International Corp
ACO
+$483K
5
JNJ icon
Johnson & Johnson
JNJ
+$450K

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.26%
2 Healthcare 13.17%
3 Consumer Staples 12.92%
4 Technology 11.77%
5 Financials 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTU icon
151
Intuit
INTU
$97.9B
$921K 0.12%
11,440
+80
+0.7% +$6.17K
BDX icon
152
Becton Dickinson
BDX
$51.6B
$900K 0.12%
7,802
+344
+5% +$39K
SYK icon
153
Stryker
SYK
$127B
$888K 0.11%
10,537
-710
-6% -$58K
IJR icon
154
iShares Core S&P Small-Cap ETF
IJR
$110B
$887K 0.11%
15,820
– –
DD
155
DELISTED
Du Pont De Nemours E I
DD
$881K 0.11%
14,169
-3,139
-18% -$202K
F icon
156
Ford
F
$55.3B
$880K 0.11%
51,039
+4,425
+9% +$72K
BIIB icon
157
Biogen
BIIB
$32.3B
$869K 0.11%
2,757
+138
+5% +$41.5K
COF icon
158
Capital One
COF
$132B
$858K 0.11%
10,388
+745
+8% +$57.9K
EEM icon
159
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$855K 0.11%
19,780
-305
-2% -$12.9K
VCR icon
160
Vanguard Consumer Discretionary ETF
VCR
$6.04B
$828K 0.11%
7,585
+110
+1% +$11.6K
IWF icon
161
iShares Russell 1000 Growth ETF
IWF
$126B
$820K 0.11%
36,088
– –
SYY icon
162
Sysco
SYY
$39.3B
$816K 0.11%
21,785
-2,310
-10% -$84.8K
AIG icon
163
American International
AIG
$40.2B
$787K 0.1%
14,414
+1,810
+14% +$95.8K
MPC icon
164
Marathon Petroleum
MPC
$104B
$785K 0.1%
20,098
-640
-3% -$28.3K
VBK icon
165
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24B
$764K 0.1%
6,000
– –
MDY icon
166
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
$751K 0.1%
2,883
– –
MON
167
DELISTED
Monsanto Co
MON
$745K 0.1%
5,972
+11
+0.2% +$1.29K
ELV icon
168
Elevance Health
ELV
$85.5B
$743K 0.1%
6,900
-430
-6% -$44.3K
GRFS
169
Grifois
GRFS
$5.23B
$730K 0.09%
33,122
-2,500
-7% -$52.3K
SU icon
170
Suncor Energy
SU
$76.5B
$717K 0.09%
16,819
-320
-2% -$12.5K
WDFC icon
171
WD-40
WDFC
$2.91B
$650K 0.08%
8,644
– –
CMCSK
172
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$642K 0.08%
12,035
-143
-1% -$7.63K
VIS icon
173
Vanguard Industrials ETF
VIS
$8.07B
$635K 0.08%
6,095
– –
PRU icon
174
Prudential Financial
PRU
$41.3B
$634K 0.08%
7,147
+545
+8% +$45.8K
VUG icon
175
Vanguard Morningstar Growth ETF
VUG
$228B
$623K 0.08%
37,788
-2,364
-6% -$37.5K
5 6
7
8 9

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q2 2014 Portfolio in Review

As of Q2 2014, Dowling & Yahnke held 284 positions worth $774M, up 2% from $759M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke's Q2 2014 filing shows 7 new, 63 increased, 151 reduced and 12 closed positions. Its largest new stake was Allergan plc: 949 shares worth $212K. The largest sale was Coca-Cola, an estimated $978K.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dowling & Yahnke's largest Q2 2014 buy was Allergan plc: 949 shares worth $212K.
  • Dowling & Yahnke added most to Interactive Brokers in Q2 2014, an estimated $920K increase.
  • Dowling & Yahnke's biggest Q2 2014 reduction was Coca-Cola, cutting an estimated $978K.
  • Dowling & Yahnke fully exited AMCOL International Corp in Q2 2014, selling an estimated $483K.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $774M portfolio in Q2 2014.
  • Dowling & Yahnke opened 7 new positions and closed 12 in Q2 2014.
  • Dowling & Yahnke's portfolio value rose 2% quarter-over-quarter to $774M.

Based on Dowling & Yahnke's 13F filing for Q2 2014, filed 15 Aug 2014.